The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011

Charles E.R. Ray; Ziv J. Haskal; Jean Francois H. Geschwind; Brian S. Funaki

doi:10.1016/j.jvir.2011.09.014

The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011

Charles E.R. Ray, Ziv J. Haskal, Jean Francois H. Geschwind, Brian S. Funaki

Research output: Contribution to journal › Comment/debate › peer-review

24 Scopus citations

Abstract

This commentary is written in response to a recent Cochrane Collaboration review published in March 2011 (1). The authors of this commentary would like to express their concerns over the conclusions of the Cochrane review, which state, "There is no firm evidence to support or refute transarterial chemoembolization (TACE) or transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)."

Original language	English (US)
Pages (from-to)	1693-1696
Number of pages	4
Journal	Journal of Vascular and Interventional Radiology
Volume	22
Issue number	12
DOIs	https://doi.org/10.1016/j.jvir.2011.09.014
State	Published - Dec 2011
Externally published	Yes

Keywords

HCC
hepatocellular carcinoma

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jvir.2011.09.014

Cite this

The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011. / Ray, Charles E.R.; Haskal, Ziv J.; Geschwind, Jean Francois H. et al.
In: Journal of Vascular and Interventional Radiology, Vol. 22, No. 12, 12.2011, p. 1693-1696.

Research output: Contribution to journal › Comment/debate › peer-review

@article{17081d3d7e024d21a044e738d5979d7d,

title = "The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011",

abstract = "This commentary is written in response to a recent Cochrane Collaboration review published in March 2011 (1). The authors of this commentary would like to express their concerns over the conclusions of the Cochrane review, which state, {"}There is no firm evidence to support or refute transarterial chemoembolization (TACE) or transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC).{"}",

keywords = "HCC, hepatocellular carcinoma",

author = "Ray, {Charles E.R.} and Haskal, {Ziv J.} and Geschwind, {Jean Francois H.} and Funaki, {Brian S.}",

year = "2011",

month = dec,

doi = "10.1016/j.jvir.2011.09.014",

language = "English (US)",

volume = "22",

pages = "1693--1696",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "12",

}

TY - JOUR

T1 - The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma

T2 - A response to the cochrane collaboration review of 2011

AU - Ray, Charles E.R.

AU - Haskal, Ziv J.

AU - Geschwind, Jean Francois H.

AU - Funaki, Brian S.

PY - 2011/12

Y1 - 2011/12

N2 - This commentary is written in response to a recent Cochrane Collaboration review published in March 2011 (1). The authors of this commentary would like to express their concerns over the conclusions of the Cochrane review, which state, "There is no firm evidence to support or refute transarterial chemoembolization (TACE) or transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)."

AB - This commentary is written in response to a recent Cochrane Collaboration review published in March 2011 (1). The authors of this commentary would like to express their concerns over the conclusions of the Cochrane review, which state, "There is no firm evidence to support or refute transarterial chemoembolization (TACE) or transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)."

KW - HCC

KW - hepatocellular carcinoma

UR - http://www.scopus.com/inward/record.url?scp=81855221737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855221737&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2011.09.014

DO - 10.1016/j.jvir.2011.09.014

M3 - Comment/debate

C2 - 22035882

AN - SCOPUS:81855221737

SN - 1051-0443

VL - 22

SP - 1693

EP - 1696

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 12

ER -

The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this